Cramer: Buying Trea...
Health Care: Drugs
Enzon Pharmaceuticals Inc. (ENZN: NASDAQ)
$6.41 -0.02 | -0.31%
06/01/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -20.76M | 177.24M | 683.00K | -2.72M |
| Operating Gains/Losses | -240.00K | 493.00K | -4.84M | -1.86M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | -4.01M | 3.24M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | -1.47M | 6.03M |
| (Increase) Decrease In Other Current Assets | 0.00 | 644.00K | -2.70M | 938.00K |
| (Decrease) Increase In Payables | -2.62M | 2.80M | -178.00K | -5.00M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 4.30M | -2.42M | 722.00K |
| (Increase) Decrease In Other Working Capital | 256.00K | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 4.74M | -171.70M | 9.89M | 9.03M |
| Net Cash From Continuing Operations | -12.72M | 22.18M | 13.89M | 30.51M |
| Net Cash From Discontinued Operations | 0.00 | 436.00K | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -12.72M | 22.62M | 13.89M | 30.51M |
| Sale of Property, Plant & Equipment | 4.00K | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 104.45M | 0.00 | 33.19M | 217.19M |
| Purchases of Property, Plant & Equipment | -630.00K | -1.97M | -8.31M | -7.89M |
| Acquisitions | 0.00 | 262.58M | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -263.06M | 0.00 | -109.79M | -126.51M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -159.24M | 343.98M | -26.15M | 82.79M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 5.87M | 32.26M | 852.00K | 1.45M |
| Repayment of Long-Term Debt | -5.00M | 0.00 | -15.60M | -74.78M |
| Repurchase of Capital Stock | -120.79M | -48.17M | -2.26M | -307.00K |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -1.32M | -3.60M | 0.00 | 0.00 |
| Net Cash From Financing Activities | -121.24M | -19.51M | -17.01M | -73.64M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -293.21M | 347.09M | -29.27M | 39.66M |
Portfolios with ENZN
- Portfolio NameUser Type
- ProSeth Klarman - Baupost Group
- ProCarl Icahn
- UserGFNN Stockdiagnostics 12
- UserVermonty #1
- ProRichard Perry - Perry Capital
- ProMichael Price - MFP Investors
- UserInternational Value Fund
- UserRichard_stocks
- ContributorBarron's Activist Stocks 5-...
- UserASCO 2010 Part 2
Latest ENZN Headlines from TheStreet
- Enzon Pharmaceuticals Inc. (ENZN): Today's Featured Drugs Loser 10.05.11 | 04:10 pm
- Enzon Stock Hits New 52-Week Low (ENZN) 09.30.11 | 03:09 pm
- Enzon Stock Hits New 52-Week Low (ENZN) 09.22.11 | 02:09 pm
- Enzon Pharmaceuticals Inc. Stock Downgraded (ENZN) 08.09.11 | 07:08 am
- Enzon Stock Hits New 52-Week Low (ENZN) 08.04.11 | 11:08 am
- Enzon Stock Hits New 52-Week Low (ENZN) 07.27.11 | 10:07 am
- Enzon Stock Hits New 52-Week Low (ENZN) 06.17.11 | 04:06 pm
- 2 New Stock Picks From Baupost's Klarman 05.16.11 | 06:05 am
- Carl Icahn Bets Big on 23 Stocks 02.16.11 | 06:02 am
- Enzon Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript 05.10.10 | 11:05 pm
Press Releases for ENZN
- Enzon Announces Reduction In Force To Align Operations With Research And Development Activities - Business Wire 09.22.11 | 04:09 pm
- ENZON Names Ana I. Stancic Chief Financial Officer - Business Wire 05.31.11 | 06:05 am
- Enzon Announces Discontinuation Of PEG-SN38 Program In Metastatic Colorectal Carcinoma In Light Of Evolving Standards Of Care - Business Wire 05.19.11 | 06:05 am
- Enzon Reports 1st Quarter 2011 Results - Business Wire 05.06.11 | 08:05 am
- Enzon Presents Data At 2011 AACR Meeting - Business Wire 04.05.11 | 04:04 pm
- Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman Of The Board; Adopts Majority Vote Standard For Election Of Directors - Business Wire 03.17.11 | 04:03 pm
- Enzon Reports 2010 Results - Business Wire 02.17.11 | 04:02 pm
- Enzon To Release Fourth Quarter 2010 Earnings On Thursday, February 17, 2011; Conference Call And Webcast To Follow - Business Wire 02.10.11 | 07:02 am
- Enzon To Begin Phase 1 Study Of Novel Androgen Receptor MRNA Antagonist In Castration-Resistant Prostate Cancer - Business Wire 01.10.11 | 07:01 am
- Enzon Board Authorizes Share Repurchase Program - Business Wire 12.21.10 | 04:12 pm
Partner Headlines for ENZN
- 5 Biotech Stocks That Could Double - Seeking Alpha 02.01.12 | 07:02 am
- Billionaire Carl Icahn's Top Stock Picks And Portfolio Activity - Seeking Alpha 11.23.11 | 08:11 am
- Tracking Seth Klarman's Baupost Group Holdings - Seeking Alpha 10.18.11 | 09:10 am
- 11 Stocks Carl Icahn And Jim Simons Are Bullish On - Seeking Alpha 09.18.11 | 09:09 am
- 10 Profitable, Small Cap Stocks With Strong Growth And Bullish Trends - Seeking Alpha 08.22.11 | 08:08 am
- Weak Top Line Widens Enzon Loss - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Weak Top Line Widens Enzon Loss - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Seth Klarman's Favorite Stock Picks - Seeking Alpha 07.26.11 | 09:07 am
- Enzon Pharmaceuticals (ENZN) - Bear of the Day - Zacks 06.15.11 | 01:06 am
- Enzon Pharmaceuticals (ENZN) - Bear of the Day - Zacks 06.07.11 | 01:06 am
